Cellceutix Corp. (CTIX.OB) Continues Development of Autism Compound, Encouraged by Large Pharmaceutical Companies Announcing Interest in Similar Compounds
Cellceutix Corp., a developer of small compounds for the treatment of cancer, autism and inflammatory diseases, issued a press release…